CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo
Cancer Research and Treatment. 2019;51(2):510-518.   Published online 2018 June 13    DOI: https://doi.org/10.4143/crt.2018.226

Excel Download

Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
Cancer Research and Treatment. 2019;51(2):510-518   Crossref logo
Link1 Link2 Link3

Phase 1 and pharmacological trial of OPB-31121, a signal transducer and activator of transcription-3 inhibitor, in patients with advanced hepatocellular carcinoma
Hepatology Research. 2015;45(13):1283-1291   Crossref logo
Link1

Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Cancer Research and Treatment. 2015;47(4):607-615   Crossref logo
Link1 Link2

A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma
European Journal of Cancer. 2013;49(5):999-1008   Crossref logo
Link1 Link2

Phase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumours
BMC Cancer. 2013;13(1):   Crossref logo
Link1 Link2 Link3

1454 POSTER A phase I dose-finding study of pemetrexed combined with paclitaxel in patients with advanced solid tumors
European Journal of Cancer Supplements. 2005;3(2):421   Crossref logo
Link1 Link2

Pilot study: rapamycin in advanced hepatocellular carcinoma
Alimentary Pharmacology & Therapeutics. 2010;32(6):763-768   Crossref logo
Link1

Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma
Cancer. 2000;89(4):750-756   Crossref logo
Link1 Link2

Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma
British Journal of Cancer. 2004;90(1):65-69   Crossref logo
Link1 Link2 Link3

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma
Journal of Hepatology. 2012;56(2):486-487   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.